HIV Citations List: December, 2016

Literature Citations

1. Precursor Forms of Vitamin D Reduce HIV-1 Infection in Vitro. Aguilar-Jimenez, W., S. Villegas-Ospina, S. Gonzalez, W. Zapata, I. Saulle, M. Garziano, M. Biasin, M. Clerici, and M.T. Rugeles. Journal of Acquired Immune Deficiency Syndromes, 2016. 73(5): p. 497-506. PMID[27509245].

[PubMed]. HIV_12_2016.

2. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells. Bam, R.A., D. Hansen, A. Irrinki, A. Mulato, G.S. Jones, J. Hesselgesser, C.R. Frey, T. Cihlar, and S.R. Yant. Antimicrobial Agents and Chemotherapy, 2017. 61(e01369-16): 14pp. PMID[27799218].
[PubMed]. HIV_12_2016.

3. In Vitro Effects of the Small-molecule Protein Kinase C Agonists on HIV Latency Reactivation. Brogdon, J., W. Ziani, X. Wang, R.S. Veazey, and H. Xu. Scientific Reports, 2016. 6(39032): 8pp. PMID[27941949]. PMCID[PMC5150635].
[PubMed]. HIV_12_2016.

4. Characterization of New Cationic N,N-Dimethyl[70]fulleropyrrolidinium iodide Derivatives as Potent HIV-1 Maturation Inhibitors. Castro, E., Z.S. Martinez, C.S. Seong, A. Cabrera-Espinoza, M. Ruiz, A. Hernandez Garcia, F. Valdez, M. Llano, and L. Echegoyen. Journal of Medicinal Chemistry, 2016. 59(24): p. 10963-10973. PMID[28002960].
[PubMed]. HIV_12_2016.

5. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. Cheeseman, H.M., N.J. Olejniczak, P.M. Rogers, A.B. Evans, D.F. King, P. Ziprin, H.X. Liao, B.F. Haynes, and R.J. Shattock. Journal of Virology, 2017. 91(e01762-16): 16pp. PMID[27795431].
[PubMed]. HIV_12_2016.

6. Hydroxyproline-containing Collagen Peptide Derived from the Skin of the Alaska Pollack Inhibits HIV-1 Infection. Jang, I.S. and S.J. Park. Molecular Medicine Reports, 2016. 14(6): p. 5489-5494. PMID[27878297].
[PubMed]. HIV_12_2016.

7. A Novel Bispecific Peptide HIV-1 Fusion Inhibitor Targeting the N-terminal Heptad Repeat and Fusion Peptide Domains in gp41. Jiang, X., Q. Jia, L. Lu, F. Yu, J. Zheng, W. Shi, L. Cai, S. Jiang, and K. Liu. Amino Acids, 2016. 48(12): p. 2867-2873. PMID[27631437].
[PubMed]. HIV_12_2016.

8. Design, Conformation, and Crystallography of 2-Naphthyl phenyl ethers as potent anti-HIV Agents. Lee, W.G., A.H. Chan, K.A. Spasov, K.S. Anderson, and W.L. Jorgensen. ACS Medicinal Chemistry Letters, 2016. 7(12): p. 1156-1160. PMID[27994756]. PMCID[PMC5151141].
[PubMed]. HIV_12_2016.

9. Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages. Ma, T.C., R.H. Zhou, X. Wang, J.L. Li, M. Sang, L. Zhou, K. Zhuang, W. Hou, D.Y. Guo, and W.Z. Ho. Scientific Reports, 2016. 6(37383): 1pp. PMID[28008167].
[PubMed]. HIV_12_2016.

10. Synthesis of and HIV-1 Integrase Inhibition by 2-[7-(Fluorobenzyloxy)-4-oxo-4hchromen-3-yl]-1-hydroxyimidazoles. Nikitina, P.A., Tkach, II, E.S. Knyazhanskaya, M.B. Gottikh, and V.P. Perevalov. Pharmaceutical Chemistry Journal, 2016. 50(8): p. 513-518. ISI[000388948900004].
[WOS]. HIV_12_2016.

11. Total Syntheses of anti-HIV Cyclodepsipeptides Aetheramides A and B. Qi, N., Z. Wang, S.R. Allu, Q. Liu, J. Guo, and Y. He. The Journal of Organic Chemistry, 2016. 81(24): p. 12466-12471. PMID[27978762].
[PubMed]. HIV_12_2016.

12. Synthesis of HIV-1 Capsid Protein Assembly Inhibitor (CAP-1) and Its Analogues Based on a Biomass Approach. Romashov, L.V. and V.P. Ananikov. Organic & Biomolecular Chemistry, 2016. 14(45): p. 10593-10598. PMID[27714265].
[PubMed]. HIV_12_2016.

13. Anti-HIV Natural Products (28): Preparation of Conjugate for 3-O-Acyl Betulin Derivative and AZT as anti-HIV Agents. Wada, S., N. Tanaka, C.H. Chen, S.L. Morris-Natschke, K.H. Lee, and Y. Kashiwada. Planta Medica, 2016. 81(S 01): p. S1-S381. PMID[27975981].
[PubMed]. HIV_12_2016.

14. A Helical Short-peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. Xiong, S., P. Borrego, X. Ding, Y. Zhu, A. Martins, H. Chong, N. Taveira, and Y. He. Journal of Virology, 2017. 91(e01839-16). PMID[27795437].

[PubMed]. HIV_12_2016.

15. Lindenane Sesquiterpenoid Dimers from Chloranthus japonicus Inhibit HIV-1 and HCV Replication. Yan, H., M.Y. Ba, X.H. Li, J.M. Guo, X.J. Qin, L. He, Z.Q. Zhang, Y. Guo, and H.Y. Liu. Fitoterapia, 2016. 115: p. 64-68. PMID[27705755].
[PubMed]. HIV_12_2016.

Patent Citations

16. Preparation of Thienopyrimidine Derivatives and for Treating HIV Infection. Liu, X., D. Kang, P. Zhan, Z. Fang, and Z. Li. Patent. 2016. 2015-CN99924 2016197589: 52pp.

[Patent]. HIV_12_2016.

17. Treatment Agents for Inhibiting HIV and Cancer in HIV Infected Patients Using an mTOR Inhibitor. Redfield, R.R., A. Heredia, C.E. Davis, R.B. Gartenhaus, and E.A. Sausville. Patent. 2016. 2016-15159444 20160339030: 36pp.

[Patent]. HIV_12_2016.

18. 5-Oxopyrrolidine Derivatives as HIV Integrase Inhibitors for Treatment of HIV Infection. Wang, X.S. Patent. 2016. 2016-15220049 20160347739: 14pp , Cont-in-part of Appl No PCT/US2015/017810.

[Patent]. HIV_12_2016.

19. Preparation of Fused Tricyclic Heterocyclic Compds. Useful for the Treatment of HIV Infection. Yu, T., T.H. Graham, S.T. Waddell, J.A. McCauley, A.W. Stamford, J.M. Sanders, L. Hu, J. Cai, and L. Zhao. Patent. 2016. 2015-CN79730 2016187788: 64pp.

[Patent]. HIV_12_2016.

20. Preparation of Fused Tricyclic Heterocyclic Compounds Useful for Treating HIV Infection. Yu, T., T.H. Graham, S.T. Waddell, J.A. McCauley, A.W. Stamford, J.M. Sanders, L. Hu, J. Cai, and L. Zhao. Patent. 2016. 2016-US33414 2016191239: 89pp.

[Patent]. HIV_12_2016.